Drug-Facilitated Sexual Assault With Tetrahydrozoline (Visine)

Author:

Edwards Carrie Nelms1,Tilley Donna Scott2,Ayala Francisco2

Affiliation:

1. Author Affiliations:School of Nursing, Texas Tech University Health Sciences Center

2. College of Nursing, Texas Woman's University.

Abstract

ABSTRACT This is a case presentation of an 18-year-old male victim who experienced a drug-facilitated sexual assault (DFSA). The drug used to incapacitate him was tetrahydrozoline (Visine) given rectally. Tetrahydrozoline, intended for ophthalmic administration, is in the class of drugs known as imidazoline receptor agonists and has been used as an agent for DFSA since the 1940s. DFSA is increasing, particularly among young men. Care of victims of DFSA is discussed with particular attention to mental health sequelae in this patient population.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Law,Nursing (miscellaneous),Psychiatry and Mental health,General Medicine,Pshychiatric Mental Health,Pathology and Forensic Medicine,Issues, ethics and legal aspects

Reference16 articles.

1. A global epidemiological perspective on the toxicology of drug-facilitated sexual assault: A systematic review;Journal of Forensic and Legal Medicine,2017

2. Drug-facilitated sexual assaults (DFSA): A serious underestimated issue;European Review for Medical and Pharmacological Sciences,2019

3. Tetrahydrozoline (Visine®) concentrations in serum and urine during therapeutic ocular dosing: A necessary first step in determining an overdose;Clinical Toxicology,2011

4. Violence against women and drug-facilitated sexual assault (DFSA): A review of the main drugs;Journal of Forensic and Legal Medicine,2020

5. Drug-facilitated sexual assault, impaired trauma memory, and implications for mental health treatment;European Journal of Psychotraumatology,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3